Government’s response to
the consultation - A new value-based approach to the pricing of
branded medicines
The Government
will continue to develop a new value-based pricing system that
will help NHS patients get better access to innovative medicines
Health Secretary Andrew Lansley today confirmed. A Written
Ministerial Statement has been laid in the House.
The Government’s response to the consultation - A new value-based
approach to the pricing of branded medicines - sets out our
intention to work with the patients, clinicians, the NHS and the
pharmaceutical industry to develop a value-based pricing system
that ensures that NHS patients have consistently good access to
medicines that they need.
Andrew Lansley said:
“We are modernising the NHS so we can give patients better access
to the medicines they need. To do this we need to change the way
drugs are priced and ensure value for money for the NHS.
“It is vital that doctors are able to prescribe medicines that
they think will benefit their patients. They must be able to focus
on what matters most – achieving the best health outcomes for
their patient, not debating the price of a drug. Value-based
pricing will ensure this happens.
“I am grateful to everyone who gave their views in the
consultation and I am now looking forward to working with
clinicians, the NHS and the pharmaceutical industry to develop a
system that encourages medical research and rewards truly
innovative breakthrough drugs.”
Contacts:
Department of Health
Phone: 020 7210 5221
NDS.DH@coi.gsi.gov.uk